Menu Search
Equities

Medical Marijuana Inc

MJNA:PKC

Medical Marijuana Inc

Actions
  • Price (USD)0.0011
  • Today's Change0.000 / 10.00%
  • Shares traded6.70m
  • 1 Year change-81.03%
  • Beta1.1844
Data delayed at least 15 minutes, as of Sep 26 2024 21:09 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medical Marijuana, Inc. manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products through e-commerce, direct sales, retail and wholesale distribution channels. It operates in four divisions. Medical Marijuana, Inc. division operates its Website to maintain an online presence, provide corporate, investor relations and educational information and news relating to it and the cannabis industry. HempMeds division distributes products directly in the United States and through its subsidiaries internationally primarily in Mexico and Brazil. Its product is Real Scientific Hemp Oil (RSHO). RSHO is a full spectrum, complete CBD hemp oil, which contains the natural hemp oil in the industry. RSHO is offered in three varieties: Green, Blue and Gold. Kannaway is its direct selling division, which sells its CBD products in United States, Europe and Asia. Its manufacturing facility division provides small-to-large scale Research & Development, Kitting, and others.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2005
  • Employees--
More ▼

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Retirement Investment Advisors, Inc.as of 30 Jun 202420.00k0.00%
Vermillion & White Wealth Management Group LLCas of 30 Jun 20241.27k0.00%
Huntington National Bank (Investment Management)as of 30 Jun 20241.00k0.00%
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.